课题基金 / 基金详情

In vitro maturation of human immunodeficiency virus type 1 Gag virus-like particle

In vitro maturation of human immunodeficiency virus type 1 Gag virus-like particle
人类免疫缺陷病毒1型Gag病毒样颗粒的体外成熟
批准号:
11670309
负责人:
MORIKAWA Yuko
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

MORIKAWA Yuko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Human immunodeficiency virus (HIV) Gag proteins are assembled underneath the plasma membrane to form the budding virus particles. During or after budding, the particles undergo the process termed maturation in which Gag is cleaved by virion-containing HIV protease to yield the N-terminal matrix (MA), the central capsid (CA), the nucleocapsid (NC), the C-terminal p6 proteins. Concomitant with the processing, doughnut-like HIV particles (the immature form) are converted to particles containing condensed cores (the mature form). As the immature particles are non-infectious, the maturation process are essential for HIV infectivity. However, it is difficult to undestand nature of Gag processing in cell-based experiments as the process of virus particle budding and that of Gag processing are interlinked and neither process is not synchronized. To understand this process, we carried out the in vitro processing of immature HIV Gag virus-like particle (VLP) by exogenously added HIV protease. Fo … More llowing delipidization with Triton X-100, sequential processing of immature VLP was carried out in acidic or neutral buffers with different concentrations of salt and confirmed the optimum activity for HIV PR (mildly acidic pH and low salt concentration). Under all conditions tested, the MA/CA junction was cleaved faster than the CA/NC junction, an altered order of processing when compared with authentic processing. When the in vitro- processed VLP was analyzed on sucrose density gradients, most of MA, CA-p15 intermediate, and NC were detected as a highly multimeric form, equivalent to the unprocessed VLP.Reverse transcriptase, a processing product of the Pot region, was also found associated to the highly multimeric complex. In contrast, CA was found as a monomer dissociated from the multimeric CA-p15 following cleavage of the CA/NC junction. Electron microscopy revealed that the in vitro processing was accompanied by conversion of the doughnut-like particles to particles containing outer shells (which may correspond to a multimer of MA) and condensed cores (likely corresponding to a complex of NC and RNA). Chracteristic of most of the cores was the absence of core shells. These results imply that the processing order in VLP may be important for core shell formation but not outer shell or core formation. To examine whether in vitro processing of the immature particles leads to produce infectious particles, we initially explored a method by which the lipid bilayer of VLP was permeabilized without a loss of viral envelope protein.Immature pseudotype particles was prepared by co-transfection with HIV proviral DNA clone whose PR was inactive and env gene was replaced with the GFP gene and expression plasmid of vesicular stomatitis virus G protein. Following in vitro processing, the processed pseudotype particles were inoculated on 239T or HeLa cells. The level of GFP expression will clarify whether or not the in vitro-processed particles are capable to produce integration-competent replication complexes. Less
期刊论文(20)
专著(0)
科研奖励(0)
会议论文
Y.Morikawa, D.Hockley, M.Nermut, and I.Jones: "Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly"J.Virol.. 74. 16-23 (2000)
Y.Morikawa、D.Hockley、M.Nermut 和 I.Jones:“人类免疫缺陷病毒 1 型 Gag 组装中基质、p2 和 N 末端肉豆蔻酰化的作用”J.Virol.. 74. 16-23 (2000
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
S.Harada,E.Haneda,Y.Morikawa,S.Funayama, et al.: "Casein kinase II (CK-II)-mediated stimulation of HIV-1 reverse transcriptase activity and characterization of selective inhibitors in vitro"Biol.Pharm.Bull.. 22. 1122-1126 (1999)
S.Harada、E.Haneda、Y.Morikawa、S.Funayama 等人:“酪蛋白激酶 II (CK-II) 介导的 HIV-1 逆转录酶活性刺激和体外选择性抑制剂的表征”Biol.Pharm
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Y.Morikawa,D.Hockley M.Nermut,and I.Jones: "Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly"J.Virol.. 74. 16-23 (2000)
Y.Morikawa、D.Hockley M.Nermut 和 I.Jones:“人类免疫缺陷病毒 1 型 Gag 组装中基质、p2 和 N 末端肉豆蔻酰化的作用”J.Virol.. 74. 16-23 (2000)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
森川裕子、櫻木小百合: "HIV粒子アッセンブリ-"医学のあゆみ. 189. 997-1001 (1999)
Yuko Morikawa,Sakuragi:“HIV 粒子组装”医学史 189. 997-1001 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
16
    The determinants of health literacy and social capital among workers and those effects on health
    • 批准号:
      18K10093
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2018
    • 负责人:
      MORIKAWA Yuko
    • 依托单位:
    Molecular modification for MHC class I and II antigen presentation
    • 批准号:
      24659211
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      MORIKAWA Yuko
    • 依托单位:
    Live-cell imaging of HIV replication component trafficking and assembly
    • 批准号:
      22390091
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2010
    • 负责人:
      MORIKAWA Yuko
    • 依托单位:
    A study on the relation of shift work on hormonal change and diseases of prostate
    • 批准号:
      22590557
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2010
    • 负责人:
      MORIKAWA Yuko
    • 依托单位:
    国内基金
    海外基金
    TMEM30A介导的磷脂酰丝氨酸外翻促进毛细胞-SGN突触发育成熟的机制研究
    • 批准号:
      82371172
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      杨光
    • 依托单位:
    神经胶质成熟因子-β对肝星状细胞活化和肝纤维化的影响及其机制研究
    • 批准号:
      30800508
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      19.0万元
    • 批准年份:
      2008
    • 负责人:
      饶慧瑛
    • 依托单位: